Incidence and mortality rates of breast cancer are expected to increase significantly due to its tumor heterogeneity and genetic factors, including type LminalA, LminalB, three negative breast cancer (TNBC), and Her2 positive breast cancer [5–7]. This evidence concerns the gene ERBB2 and breast carcinoma.